10-Q Filing
Filing Information
| Form Type | 10-Q |
| Accession Number | 0001628280-20-008635 |
| Period End Date | 20200331 |
| Filing Date | 20200529 |
| Fiscal Year | 2020 |
| Fiscal Period | Q1 |
| XBRL Instance | ameh-20200331.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
101 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$80.89M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$93.01M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$103.19M | USD | Point-in-time |
| Restricted cash |
RestrictedCashCurrent
|
$75.00K | USD | Point-in-time |
| Restricted cash |
RestrictedCashCurrent
|
$75.00K | USD | Point-in-time |
| Common Stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Common Stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Investment in marketable securities |
MarketableSecuritiesCurrent
|
$117.08M | USD | Point-in-time |
| Investment in marketable securities |
MarketableSecuritiesCurrent
|
$116.54M | USD | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
100.00M | shares | Point-in-time |
| Receivables, net |
AccountsReceivableNetCurrent
|
$11.00M | USD | Point-in-time |
| Receivables, net |
AccountsReceivableNetCurrent
|
$18.01M | USD | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
100.00M | shares | Point-in-time |
| Receivables, net related parties |
AccountsReceivableRelatedPartiesCurrent
|
$48.14M | USD | Point-in-time |
| Receivables, net related parties |
AccountsReceivableRelatedPartiesCurrent
|
$50.91M | USD | Point-in-time |
| Common stock, shares outstanding (in shares) |
CommonStockSharesOutstanding
|
36.04M | shares | Point-in-time |
| Common stock, shares outstanding (in shares) |
CommonStockSharesOutstanding
|
35.91M | shares | Point-in-time |
| Other receivables |
OtherReceivablesNetCurrent
|
$16.36M | USD | Point-in-time |
| Treasury shares (in shares) |
TreasuryStockCommonShares
|
17.48M | shares | Point-in-time |
| Other receivables |
OtherReceivablesNetCurrent
|
$16.89M | USD | Point-in-time |
| Treasury shares (in shares) |
TreasuryStockCommonShares
|
17.46M | shares | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$10.31M | USD | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$11.81M | USD | Point-in-time |
| Loans receivable |
NotesAndLoansReceivableNetCurrent
|
$6.42M | USD | Point-in-time |
| Loans receivable |
NotesAndLoansReceivableNetCurrent
|
$6.42M | USD | Point-in-time |
| Loans receivable related parties |
NotesReceivableRelatedPartiesCurrent
|
$16.50M | USD | Point-in-time |
| Loans receivable related parties |
NotesReceivableRelatedPartiesCurrent
|
$16.50M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$318.06M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$329.07M | USD | Point-in-time |
| Land, property and equipment, net |
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
|
$11.88M | USD | Point-in-time |
| Land, property and equipment, net |
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
|
$12.13M | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$103.01M | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$98.84M | USD | Point-in-time |
| Goodwill |
Goodwill
|
$238.54M | USD | Point-in-time |
| Goodwill |
Goodwill
|
$238.50M | USD | Point-in-time |
| Investment in other entities equity method |
EquityMethodInvestments
|
$30.78M | USD | Point-in-time |
| Investment in other entities equity method |
EquityMethodInvestments
|
$28.43M | USD | Point-in-time |
| Investments in privately held entities |
InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue
|
$896.00K | USD | Point-in-time |
| Investments in privately held entities |
InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue
|
$896.00K | USD | Point-in-time |
| Restricted cash |
RestrictedCashNoncurrent
|
$746.00K | USD | Point-in-time |
| Restricted cash |
RestrictedCashNoncurrent
|
$746.00K | USD | Point-in-time |
| Operating lease right-of-use assets |
OperatingLeaseRightOfUseAsset
|
$18.20M | USD | Point-in-time |
| Operating lease right-of-use assets |
OperatingLeaseRightOfUseAsset
|
$14.25M | USD | Point-in-time |
| Other assets |
OtherAssetsNoncurrent
|
$1.68M | USD | Point-in-time |
| Other assets |
OtherAssetsNoncurrent
|
$6.47M | USD | Point-in-time |
| Total noncurrent assets |
AssetsNoncurrent
|
$406.35M | USD | Point-in-time |
| Total noncurrent assets |
AssetsNoncurrent
|
$399.64M | USD | Point-in-time |
| Total assets |
Assets
|
$728.71M | USD | Point-in-time |
| Total assets |
Assets
|
$724.41M | USD | Point-in-time |
| Accounts payable and accrued expenses |
AccountsPayableAndAccruedLiabilitiesCurrent
|
$27.28M | USD | Point-in-time |
| Accounts payable and accrued expenses |
AccountsPayableAndAccruedLiabilitiesCurrent
|
$20.11M | USD | Point-in-time |
| Fiduciary accounts payable |
FiduciaryAccountsPayableCurrent
|
$1.71M | USD | Point-in-time |
| Fiduciary accounts payable |
FiduciaryAccountsPayableCurrent
|
$2.03M | USD | Point-in-time |
| Medical liabilities |
LiabilityForClaimsAndClaimsAdjustmentExpense
|
$63.70M | USD | Point-in-time |
| Medical liabilities |
LiabilityForClaimsAndClaimsAdjustmentExpense
|
$23.27M | USD | Point-in-time |
| Medical liabilities |
LiabilityForClaimsAndClaimsAdjustmentExpense
|
$33.64M | USD | Point-in-time |
| Medical liabilities |
LiabilityForClaimsAndClaimsAdjustmentExpense
|
$58.73M | USD | Point-in-time |
| Income taxes payable |
AccruedIncomeTaxesCurrent
|
$8.03M | USD | Point-in-time |
| Income taxes payable |
AccruedIncomeTaxesCurrent
|
$4.53M | USD | Point-in-time |
| Dividend payable |
DividendsPayableCurrent
|
$271.00K | USD | Point-in-time |
| Dividend payable |
DividendsPayableCurrent
|
$337.00K | USD | Point-in-time |
| Finance lease liabilities |
FinanceLeaseLiabilityCurrent
|
$102.00K | USD | Point-in-time |
| Finance lease liabilities |
FinanceLeaseLiabilityCurrent
|
$102.00K | USD | Point-in-time |
| Operating lease liabilities |
OperatingLeaseLiabilityCurrent
|
$3.12M | USD | Point-in-time |
| Operating lease liabilities |
OperatingLeaseLiabilityCurrent
|
$2.99M | USD | Point-in-time |
| Current portion of long-term debt |
LongTermDebtCurrent
|
$9.50M | USD | Point-in-time |
| Current portion of long-term debt |
LongTermDebtCurrent
|
$9.50M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$105.42M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$106.61M | USD | Point-in-time |
| Deferred tax liability |
DeferredIncomeTaxLiabilitiesNet
|
$16.33M | USD | Point-in-time |
| Deferred tax liability |
DeferredIncomeTaxLiabilitiesNet
|
$18.27M | USD | Point-in-time |
| Finance lease liabilities, net of current portion |
FinanceLeaseLiabilityNoncurrent
|
$390.00K | USD | Point-in-time |
| Finance lease liabilities, net of current portion |
FinanceLeaseLiabilityNoncurrent
|
$416.00K | USD | Point-in-time |
| Operating lease liabilities, net of current portion |
OperatingLeaseLiabilityNoncurrent
|
$11.37M | USD | Point-in-time |
| Operating lease liabilities, net of current portion |
OperatingLeaseLiabilityNoncurrent
|
$15.58M | USD | Point-in-time |
| Long-term debt, net of current portion and deferred financing costs |
LongTermDebtNoncurrent
|
$230.10M | USD | Point-in-time |
| Long-term debt, net of current portion and deferred financing costs |
LongTermDebtNoncurrent
|
$232.17M | USD | Point-in-time |
| Total noncurrent liabilities |
LiabilitiesNoncurrent
|
$262.41M | USD | Point-in-time |
| Total noncurrent liabilities |
LiabilitiesNoncurrent
|
$262.23M | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$369.01M | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$367.65M | USD | Point-in-time |
| Commitments and contingencies (Note 11) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Commitments and contingencies (Note 11) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Noncontrolling interest in Allied Physicians of California, a Professional Medical Corporation |
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
|
$168.72M | USD | Point-in-time |
| Noncontrolling interest in Allied Physicians of California, a Professional Medical Corporation |
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
|
$157.44M | USD | Point-in-time |
| Common stock, $0.001 par value per share; 100,000,000 shares authorized, 36,042,761 and 35,908,057 shares outstanding, excluding 17,475,707 and 17,458,810 treasury shares, at March 31, 2020, and December 31, 2019, respectively |
CommonStockValue
|
$36.00K | USD | Point-in-time |
| Common stock, $0.001 par value per share; 100,000,000 shares authorized, 36,042,761 and 35,908,057 shares outstanding, excluding 17,475,707 and 17,458,810 treasury shares, at March 31, 2020, and December 31, 2019, respectively |
CommonStockValue
|
$36.00K | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$161.09M | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$159.61M | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$31.91M | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$35.96M | USD | Point-in-time |
| Retained earnings |
StockholdersEquity
|
$191.55M | USD | Point-in-time |
| Retained earnings |
StockholdersEquity
|
$197.08M | USD | Point-in-time |
| Noncontrolling interest |
MinorityInterest
|
$881.00K | USD | Point-in-time |
| Noncontrolling interest |
MinorityInterest
|
$786.00K | USD | Point-in-time |
| Total stockholders equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$197.96M | USD | Point-in-time |
| Total stockholders equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$182.38M | USD | Point-in-time |
| Total stockholders equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$181.54M | USD | Point-in-time |
| Total stockholders equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$192.34M | USD | Point-in-time |
| Total liabilities, mezzanine equity and stockholders equity |
LiabilitiesAndStockholdersEquity
|
$728.71M | USD | Point-in-time |
| Total liabilities, mezzanine equity and stockholders equity |
LiabilitiesAndStockholdersEquity
|
$724.41M | USD | Point-in-time |
Income Statement
42 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Total revenue |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$165.10M | USD | 1 Quarter |
| Total revenue |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$95.76M | USD | 1 Quarter |
| Cost of services |
CostOfGoodsAndServicesSold
|
$83.43M | USD | 1 Quarter |
| Cost of services |
CostOfGoodsAndServicesSold
|
$144.20M | USD | 1 Quarter |
| General and administrative expenses |
GeneralAndAdministrativeExpense
|
$10.26M | USD | 1 Quarter |
| General and administrative expenses |
GeneralAndAdministrativeExpense
|
$11.83M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts
|
$4.42M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts
|
$4.70M | USD | 1 Quarter |
| Provision for doubtful accounts |
ProvisionForDoubtfulAccounts
|
- | USD | 1 Quarter |
| Provision for doubtful accounts |
ProvisionForDoubtfulAccounts
|
$951.00K | USD | 1 Quarter |
| Total expenses |
CostsAndExpenses
|
$99.06M | USD | 1 Quarter |
| Total expenses |
CostsAndExpenses
|
$160.74M | USD | 1 Quarter |
| Income (loss) from operations |
OperatingIncomeLoss
|
$4.37M | USD | 1 Quarter |
| Income (loss) from operations |
OperatingIncomeLoss
|
$-3.31M | USD | 1 Quarter |
| Income (loss) from equity method investments |
IncomeLossFromEquityMethodInvestments
|
$-850.00K | USD | 1 Quarter |
| Income (loss) from equity method investments |
IncomeLossFromEquityMethodInvestments
|
$2.05M | USD | 1 Quarter |
| Interest expense |
InterestExpense
|
$2.87M | USD | 1 Quarter |
| Interest expense |
InterestExpense
|
$211.00K | USD | 1 Quarter |
| Interest income |
InvestmentIncomeInterest
|
$929.00K | USD | 1 Quarter |
| Interest income |
InvestmentIncomeInterest
|
$323.00K | USD | 1 Quarter |
| Other income |
OtherNonoperatingIncomeExpense
|
$102.00K | USD | 1 Quarter |
| Other income |
OtherNonoperatingIncomeExpense
|
$187.00K | USD | 1 Quarter |
| Total other income (expense), net |
NonoperatingIncomeExpense
|
$-551.00K | USD | 1 Quarter |
| Total other income (expense), net |
NonoperatingIncomeExpense
|
$217.00K | USD | 1 Quarter |
| Income (loss) before provision for (benefit from) income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$4.58M | USD | 1 Quarter |
| Income (loss) before provision for (benefit from) income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$-3.86M | USD | 1 Quarter |
| Provision for (benefit from) income taxes |
IncomeTaxExpenseBenefit
|
$-1.41M | USD | 1 Quarter |
| Provision for (benefit from) income taxes |
IncomeTaxExpenseBenefit
|
$1.59M | USD | 1 Quarter |
| Net income (loss) |
ProfitLoss
|
$-2.45M | USD | 1 Quarter |
| Net income (loss) |
ProfitLoss
|
$2.99M | USD | 1 Quarter |
| Net loss attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
$-1.06M | USD | 1 Quarter |
| Net loss attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
$-2.59M | USD | 1 Quarter |
| Net income attributable to Apollo Medical Holdings, Inc. |
NetIncomeLoss
|
$140.00K | USD | 1 Quarter |
| Net income attributable to Apollo Medical Holdings, Inc. |
NetIncomeLoss
|
$4.05M | USD | 1 Quarter |
| Earnings per share basic (in dollars per share) |
EarningsPerShareBasic
|
$0.11 | USD | 1 Quarter |
| Earnings per share basic (in dollars per share) |
EarningsPerShareBasic
|
- | USD | 1 Quarter |
| Earnings per share diluted (in dollars per share) |
EarningsPerShareDiluted
|
- | USD | 1 Quarter |
| Earnings per share diluted (in dollars per share) |
EarningsPerShareDiluted
|
$0.11 | USD | 1 Quarter |
| Weighted average shares of common stock outstanding basic (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
36.01M | shares | 1 Quarter |
| Weighted average shares of common stock outstanding basic (in shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
34.50M | shares | 1 Quarter |
| Weighted average shares of common stock outstanding diluted (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
37.44M | shares | 1 Quarter |
| Weighted average shares of common stock outstanding diluted (in shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
38.07M | shares | 1 Quarter |
Cash Flow Statement
85 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net income (loss) |
ProfitLoss
|
$-2.45M | USD | 1 Quarter |
| Net income (loss) |
ProfitLoss
|
$2.99M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$5.01M | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$4.42M | USD | 1 Quarter |
| Provision for doubtful accounts |
ProvisionForDoubtfulAccounts
|
- | USD | 1 Quarter |
| Provision for doubtful accounts |
ProvisionForDoubtfulAccounts
|
$951.00K | USD | 1 Quarter |
| Share-based compensation |
ShareBasedCompensation
|
$345.00K | USD | 1 Quarter |
| Share-based compensation |
ShareBasedCompensation
|
$1.06M | USD | 1 Quarter |
| Unrealized gain from investment in equity securities |
UnrealizedGainLossOnInvestments
|
$162.00K | USD | 1 Quarter |
| Unrealized gain from investment in equity securities |
UnrealizedGainLossOnInvestments
|
$8.00K | USD | 1 Quarter |
| (Income) loss from equity method investments |
IncomeLossFromEquityMethodInvestments
|
$-850.00K | USD | 1 Quarter |
| (Income) loss from equity method investments |
IncomeLossFromEquityMethodInvestments
|
$2.05M | USD | 1 Quarter |
| Deferred tax |
DeferredIncomeTaxesAndTaxCredits
|
$-2.62M | USD | 1 Quarter |
| Deferred tax |
DeferredIncomeTaxesAndTaxCredits
|
$-1.92M | USD | 1 Quarter |
| Receivable, net |
IncreaseDecreaseInAccountsReceivable
|
$7.04M | USD | 1 Quarter |
| Receivable, net |
IncreaseDecreaseInAccountsReceivable
|
$-487.00K | USD | 1 Quarter |
| Receivable, net related parties |
IncreaseDecreaseInDueFromRelatedParties
|
$7.51M | USD | 1 Quarter |
| Receivable, net related parties |
IncreaseDecreaseInDueFromRelatedParties
|
$2.77M | USD | 1 Quarter |
| Other receivables |
IncreaseDecreaseInOtherReceivables
|
$11.24M | USD | 1 Quarter |
| Other receivables |
IncreaseDecreaseInOtherReceivables
|
$-521.00K | USD | 1 Quarter |
| Prepaid expenses and other current assets |
IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets
|
$1.50M | USD | 1 Quarter |
| Prepaid expenses and other current assets |
IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets
|
$729.00K | USD | 1 Quarter |
| Right-of-use assets |
IncreaseDecreaseInOperatingLeaseAssets
|
$448.00K | USD | 1 Quarter |
| Right-of-use assets |
IncreaseDecreaseInOperatingLeaseAssets
|
$794.00K | USD | 1 Quarter |
| Other assets |
IncreaseDecreaseInOtherOperatingAssets
|
$443.00K | USD | 1 Quarter |
| Other assets |
IncreaseDecreaseInOtherOperatingAssets
|
$4.80M | USD | 1 Quarter |
| Accounts payable and accrued expenses |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$-7.17M | USD | 1 Quarter |
| Accounts payable and accrued expenses |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$22.58M | USD | 1 Quarter |
| Fiduciary accounts payable |
IncreaseDecreaseInOtherAccountsPayable
|
$546.00K | USD | 1 Quarter |
| Fiduciary accounts payable |
IncreaseDecreaseInOtherAccountsPayable
|
$-318.00K | USD | 1 Quarter |
| Medical liabilities |
IncreaseDecreaseInMedicalLiabilities
|
$-10.38M | USD | 1 Quarter |
| Medical liabilities |
IncreaseDecreaseInMedicalLiabilities
|
$4.97M | USD | 1 Quarter |
| Income taxes payable |
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
$1.21M | USD | 1 Quarter |
| Income taxes payable |
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
$3.50M | USD | 1 Quarter |
| Operating lease liabilities |
IncreaseDecreaseInOtherOperatingLeaseLiabilities
|
$-406.00K | USD | 1 Quarter |
| Operating lease liabilities |
IncreaseDecreaseInOtherOperatingLeaseLiabilities
|
$-416.00K | USD | 1 Quarter |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-3.97M | USD | 1 Quarter |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-9.29M | USD | 1 Quarter |
| Purchases of marketable securities |
PaymentsToAcquireMarketableSecurities
|
$8.00K | USD | 1 Quarter |
| Purchases of marketable securities |
PaymentsToAcquireMarketableSecurities
|
$374.00K | USD | 1 Quarter |
| Purchases of investment equity method |
PaymentsToAcquireEquityMethodInvestments
|
$300.00K | USD | 1 Quarter |
| Purchases of investment equity method |
PaymentsToAcquireEquityMethodInvestments
|
- | USD | 1 Quarter |
| Purchases of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$104.00K | USD | 1 Quarter |
| Purchases of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$269.00K | USD | 1 Quarter |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-112.00K | USD | 1 Quarter |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-943.00K | USD | 1 Quarter |
| Repayment of bank loan and lines of credit |
RepaymentsOfBankLoanAndLinesOfCredit
|
$40.00K | USD | 1 Quarter |
| Repayment of bank loan and lines of credit |
RepaymentsOfBankLoanAndLinesOfCredit
|
- | USD | 1 Quarter |
| Dividends paid |
PaymentsOfDividends
|
$9.93M | USD | 1 Quarter |
| Dividends paid |
PaymentsOfDividends
|
$10.00M | USD | 1 Quarter |
| Repayment of term loan |
RepaymentsOfLongTermDebt
|
- | USD | 1 Quarter |
| Repayment of term loan |
RepaymentsOfLongTermDebt
|
$2.38M | USD | 1 Quarter |
| Payment of finance lease obligations |
FinanceLeasePrincipalPayments
|
$26.00K | USD | 1 Quarter |
| Payment of finance lease obligations |
FinanceLeasePrincipalPayments
|
$25.00K | USD | 1 Quarter |
| Proceeds from the exercise of stock options and warrants |
ProceedsFromWarrantExercises
|
$140.00K | USD | 1 Quarter |
| Proceeds from the exercise of stock options and warrants |
ProceedsFromWarrantExercises
|
$700.00K | USD | 1 Quarter |
| Repurchase of shares |
PaymentsForRepurchaseOfCommonStock
|
$40.00K | USD | 1 Quarter |
| Repurchase of shares |
PaymentsForRepurchaseOfCommonStock
|
$426.00K | USD | 1 Quarter |
| Proceeds from common stock offering |
ProceedsFromIssuanceOfCommonStock
|
$155.00K | USD | 1 Quarter |
| Proceeds from common stock offering |
ProceedsFromIssuanceOfCommonStock
|
- | USD | 1 Quarter |
| Net cash used in financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$-12.06M | USD | 1 Quarter |
| Net cash used in financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$-9.81M | USD | 1 Quarter |
| Net decrease in cash, cash equivalents and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$-22.30M | USD | 1 Quarter |
| Net decrease in cash, cash equivalents and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$-13.89M | USD | 1 Quarter |
| Cash, cash equivalents and restricted cash, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$81.71M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$107.64M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$93.75M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$104.01M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$81.71M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$107.64M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$93.75M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$104.01M | USD | Point-in-time |
| Cash paid for interest |
InterestPaidNet
|
$182.00K | USD | 1 Quarter |
| Cash paid for interest |
InterestPaidNet
|
$2.62M | USD | 1 Quarter |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$80.89M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$93.01M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$103.19M | USD | Point-in-time |
| Restricted cash current |
RestrictedCashEquivalentsCurrent
|
- | USD | Point-in-time |
| Restricted cash current |
RestrictedCashEquivalentsCurrent
|
$75.00K | USD | Point-in-time |
| Restricted cash non-current |
RestrictedCashEquivalentsNoncurrent
|
$740.00K | USD | Point-in-time |
| Restricted cash non-current |
RestrictedCashEquivalentsNoncurrent
|
$746.00K | USD | Point-in-time |
| Total cash, cash equivalents and restricted cash shown in the statement of cash flows |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$81.71M | USD | Point-in-time |
| Total cash, cash equivalents and restricted cash shown in the statement of cash flows |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$107.64M | USD | Point-in-time |
| Total cash, cash equivalents and restricted cash shown in the statement of cash flows |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$93.75M | USD | Point-in-time |
| Total cash, cash equivalents and restricted cash shown in the statement of cash flows |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$104.01M | USD | Point-in-time |
Stockholders Equity
19 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Equity, beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$197.96M | USD | Point-in-time |
| Equity, beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$182.38M | USD | Point-in-time |
| Equity, beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$181.54M | USD | Point-in-time |
| Equity, beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$192.34M | USD | Point-in-time |
| Net (loss) income |
NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity
|
$550.00K | USD | 1 Quarter |
| Net (loss) income |
NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity
|
$4.15M | USD | 1 Quarter |
| Purchase of treasury shares |
TreasuryStockValueAcquiredParValueMethod
|
- | USD | 1 Quarter |
| Purchase of treasury shares |
TreasuryStockValueAcquiredParValueMethod
|
$301.00K | USD | 1 Quarter |
| Purchase of noncontrolling interest |
MinorityInterestDecreaseFromRedemptions
|
- | USD | 1 Quarter |
| Shares issued for exercise of options and warrants |
StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants
|
$722.00K | USD | 1 Quarter |
| Shares issued for exercise of options and warrants |
StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants
|
$140.00K | USD | 1 Quarter |
| Share-based compensation |
StockIssuedDuringPeriodValueShareBasedCompensation
|
$143.00K | USD | 1 Quarter |
| Share-based compensation |
StockIssuedDuringPeriodValueShareBasedCompensation
|
$1.06M | USD | 1 Quarter |
| Dividends |
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
|
- | USD | 1 Quarter |
| Dividends |
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
|
- | USD | 1 Quarter |
| Equity, ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$197.96M | USD | Point-in-time |
| Equity, ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$182.38M | USD | Point-in-time |
| Equity, ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$181.54M | USD | Point-in-time |
| Equity, ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$192.34M | USD | Point-in-time |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.